Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke (MINOS)
Minocycline to Improve Neurologic Outcome in Stroke (MINOS)
Sponsor: David Hess, MD
This PHASE1/PHASE2 trial investigates Stroke, Acute and is currently completed. David Hess, MD leads this study, which shows 10 recorded versions since 2008 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed PHASE1_PHASE2
-
May 2018 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
-
Aug 2017 — May 2018 [monthly]
Completed PHASE1_PHASE2
-
Feb 2017 — Aug 2017 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1_PHASE2
First recorded
May 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- David Hess, MD
- National Institute of Neurological Disorders and Stroke (NINDS)
- Oregon Health and Science University
- University of Kentucky
For direct contact, visit the study record on ClinicalTrials.gov .